This work illuminates the molecular relationship between depression and neuroinflammation while establishing [<sup>18</sup>F]PB200 as a valuable tool for evaluating HDAC6-targeted therapeutic interventions, potentially advancing precision diagnosis and treatment approaches for depression. This evidence concerns the gene HDAC6 and depressive symptom measurement.